Bio-Key Stock Analysis

BKYI
 Stock
  

USD 1.05  0.01  0.94%   

The big decline in price over the last few months for Bio-Key Intl could raise concerns from stockholders as the firm is trading at a share price of 1.05 on 14,300 in volume. The company management teams failed to add value to investors and position the firm supply of money to exploit market volatility in October. However, diversifying your holdings with Bio-Key Intl or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.48. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Bio-Key Intl partners.
Continue to Trending Equities.
  
The Bio-Key Intl stock analysis report makes it easy to digest most publicly released information about Bio-Key Intl and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Bio-Key Stock analysis module also helps to analyze the Bio-Key Intl price relationship with some important fundamental indicators such as market cap and management efficiency.

Bio-Key Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bio-Key Intl recorded a loss per share of 2.08. The entity had not issued any dividends in recent years. The firm had 1-8 split on the 20th of November 2020. BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. For more info on Bio-Key Intl please contact Michael DePasquale at 732 359 1100 or go to https://www.bio-key.com.

Bio-Key Intl Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bio-Key Intl's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio-Key Intl or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Bio-Key Intl generated a negative expected return over the last 90 days
Bio-Key Intl has some characteristics of a very speculative penny stock
Bio-Key Intl has high historical volatility and very poor performance
Bio-Key Intl has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 6.12 M. Net Loss for the year was (5.77 M) with profit before overhead, payroll, taxes, and interest of 3.44 M.
Bio-Key Intl currently holds about 4.89 M in cash with (6.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Latest headline from news.google.com: Zoetis Announces Third Quarter 2022 Results - BioSpace

Bio-Key Intl Upcoming and Recent Events

Earnings reports are used by Bio-Key Intl to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bio-Key Intl previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of March 2022
Next Fiscal Quarter End31st of December 2021

Bio-Key Intl SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Bio-Key Intl prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Bio-Key Intl investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Bio-Key Intl specific information freely available to individual and institutional investors to make a timely investment decision.
15th of August 2022
Other Events
View
12th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
26th of July 2022
Financial Statements and Exhibits. Changes in Registrant's Certifying Accountant
View
27th of June 2022
Submission of Matters to a Vote of Security Holders
View
16th of May 2022
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
View
31st of March 2022
Other Events
View
29th of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
9th of March 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Unregistered Sales of Equity Securities. Completion of Acquisition or Disposition of Assets. Entry into a Material Definitive Agreement
View

Bio-Key Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Bio-Key Intl is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio-Key Intl backward and forwards among themselves. Bio-Key Intl's institutional investor refers to the entity that pools money to purchase Bio-Key Intl's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Wolverine Trading LlcCommon Shares15.6 K38 K
Wolverine Trading LlcPut Options27.9 K68 K
Wolverine Trading LlcCall Options19.2 K46 K
Wolverine Trading LlcCommon Shares11.8 K26 K
Wolverine Trading LlcCommon Shares12.5 K48 K
Wells Fargo CompanyCommon Shares1040.0
Wells Fargo CompanyCommon Shares97.00.0
Wells Fargo CompanyCommon Shares97.00.0
Wells Fargo CompanyCommon Shares97.00.0
Note, although Bio-Key Intl's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bio-Key Market Capitalization

The company currently falls under 'Nano-Cap' category with current market capitalization of 8.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio-Key Intl's market, we take the total number of its shares issued and multiply it by Bio-Key Intl's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Bio-Key Profitablity

Bio-Key Intl's profitability indicators refer to fundamental financial ratios that showcase Bio-Key Intl's ability to generate income relative to its revenue or operating costs. If, let's say, Bio-Key Intl is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bio-Key Intl's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bio-Key Intl's profitability requires more research than a typical breakdown of Bio-Key Intl's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (94.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (90.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.91.

Management Efficiency

The entity has return on total asset (ROA) of (18.02) % which means that it has lost $18.02 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (35.94) %, meaning that it created substantial loss on money invested by shareholders. Bio-Key Intl management efficiency ratios could be used to measure how well bio-key intl manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 26th of November, Bio-Key Intl shows the risk adjusted performance of (0.20), and Mean Deviation of 2.9. Bio-Key Intl technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Bio-Key Intl, which can be compared to its rivals. Please confirm Bio-Key Intl coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Bio-Key Intl is priced correctly, providing market reflects its regular price of 1.05 per share. Given that Bio-Key Intl is a hitting penny stock territory we recommend to closely look at its total risk alpha.

Bio-Key Intl Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Kaufman Adaptive Moving Average allows the user to define Bio-Key Intl range across which they want the smoothing.
.

Bio-Key Intl Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bio-Key Intl insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bio-Key Intl's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bio-Key Intl insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Michael DePasquale over two months ago via Macroaxis 
Purchase by Michael DePasquale of 1000 shares of Bio-Key Intl
Michael DePasquale over two months ago via Macroaxis 
Purchase by Michael DePasquale of tradable shares of Bio-Key Intl
Sullivan James David over three months ago via Macroaxis 
Purchase by Sullivan James David of 2581 shares of Bio-Key Intl
Bush Iii Thomas over three months ago via Macroaxis 
Acquisition by Bush Iii Thomas of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Pieter Knook over three months ago via Macroaxis 
Acquisition by Pieter Knook of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Robert Michel over three months ago via Macroaxis 
Acquisition by Robert Michel of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Alia Emmanuel over three months ago via Macroaxis 
Acquisition by Alia Emmanuel of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Pieter Knook over three months ago via Macroaxis 
Acquisition by Pieter Knook of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Robert Michel over three months ago via Macroaxis 
Acquisition by Robert Michel of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Thomas Gilley over three months ago via Macroaxis 
Acquisition by Thomas Gilley of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Alia Emmanuel over three months ago via Macroaxis 
Acquisition by Alia Emmanuel of 1383 shares of Bio-Key Intl subject to Rule 16b-3
Thomas Gilley over three months ago via Macroaxis 
Acquisition by Thomas Gilley of 1383 shares of Bio-Key Intl subject to Rule 16b-3

Bio-Key Intl Predictive Daily Indicators

Bio-Key Intl intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bio-Key Intl stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bio-Key Intl Forecast Models

Bio-Key Intl time-series forecasting models is one of many Bio-Key Intl's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bio-Key Intl's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bio-Key Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bio-Key Intl prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bio-Key shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Bio-Key Intl. By using and applying Bio-Key Stock analysis, traders can create a robust methodology for identifying Bio-Key entry and exit points for their positions.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.

Current Bio-Key Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bio-Key analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bio-Key analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
6.0Strong Buy1Odds
Bio-Key Intl current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bio-Key analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bio-Key stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bio-Key Intl, talking to its executives and customers, or listening to Bio-Key conference calls.
Bio-Key Analyst Advice Details

Bio-Key Stock Analysis Indicators

Bio-Key Intl stock analysis indicators help investors evaluate how Bio-Key Intl stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bio-Key Intl shares will generate the highest return on investment. By understating and applying Bio-Key Intl stock analysis, traders can identify Bio-Key Intl position entry and exit signals to maximize returns.
Quick Ratio1.98
Fifty Two Week Low0.9900
Revenue Growth96.30%
Shares Short Prior Month89.83k
Average Daily Volume Last 10 Day30.41k
Average Daily Volume In Three Month12.04k
Shares Percent Shares Out0.93%
Gross Margins71.77%
Short Percent Of Float1.02%
Forward Price Earnings6.35
Float Shares7.62M
Fifty Two Week High2.9000
Enterprise Value To Ebitda-1.78
Fifty Day Average1.5242
Two Hundred Day Average1.8701
Enterprise Value To Revenue1.58
Continue to Trending Equities. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for analysis

When running Bio-Key Intl price analysis, check to measure Bio-Key Intl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Key Intl is operating at the current time. Most of Bio-Key Intl's value examination focuses on studying past and present price action to predict the probability of Bio-Key Intl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bio-Key Intl's price. Additionally, you may evaluate how the addition of Bio-Key Intl to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Bio-Key Intl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio-Key Intl. If investors know Bio-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio-Key Intl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
9.1 M
Quarterly Revenue Growth YOY
0.058
Return On Assets
(0.24) 
Return On Equity
(0.50) 
The market value of Bio-Key Intl is measured differently than its book value, which is the value of Bio-Key that is recorded on the company's balance sheet. Investors also form their own opinion of Bio-Key Intl's value that differs from its market value or its book value, called intrinsic value, which is Bio-Key Intl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio-Key Intl's market value can be influenced by many factors that don't directly affect Bio-Key Intl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio-Key Intl's value and its price as these two are different measures arrived at by different means. Investors typically determine Bio-Key Intl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Key Intl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.